1-2 of 2
Christine Nichols
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1b, Dose Escalation/Dose Expansion, Multicenter, Open-Label Study to Assess the Safety and Tolerability of OPN-6602 Monotherapy and in Combination with Dexamethasone in Subjects with Relapsed and/or Refractory Multiple Myeloma

Jackie M. Walling, Bernice Matusow, Christine Nichols, Parmveer Singh, Kerry Inokuchi, Gideon Bollag
Journal: Blood
Blood (2024) 144 (Supplement 1): 7022.
https://doi.org/10.1182/blood-2024-205626
Published: 2024
Journal Articles

OPN-6602, an Orally Bioavailable EP300/CBP Bromodomain Inhibitor, Targets Multiple Myeloma through Suppression of IRF4 and MYC

Bernice Matusow, Sadegh Saghafinia, Pei Pei Li, Amanda Kohler, Pan-Yu Chen, Christine Nichols, Parmveer Singh, Kerry Inokuchi, Jackie M. Walling, Gideon Bollag
Journal: Blood
Blood (2024) 144 (Supplement 1): 1908.
https://doi.org/10.1182/blood-2024-208181
Published: 2024